✦ LIBER ✦

Personalized Medicine in Non-Small-Cell Lung Cancer: Is KRAS a Useful Marker in Selecting Patients for Epidermal Growth Factor Receptor-Targeted Therapy?

✍ Scribed by Roberts, P. J.; Stinchcombe, T. E.; Der, C. J.; Socinski, M. A.

Book ID: 111873153
Publisher: American Society of Clinical Oncology
Year: 2010
Tongue: English
Weight: 313 KB
Volume: 28
Category: Article
ISSN: 0732-183X
DOI: 10.1200/jco.2009.27.4365

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Characterization of epidermal growth fac

Characterization of epidermal growth factor receptor mutations in non-small-cell lung cancer patients of African-American ancestry

✍ Harada, T; Lopez-Chavez, A; Xi, L; Raffeld, M; Wang, Y; Giaccone, G 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 897 KB

Insulin-like growth factor type I recept

Insulin-like growth factor type I receptor: a new target in the treatment of non-small cell lung cancer patients

✍ G. Heller; S. Zöchbauer-Müller 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 188 KB

Epidermal growth factor receptor (EGFR)

Epidermal growth factor receptor (EGFR) downstream molecules as response predictive markers for gefitinib (Iressa®, ZD1839) in chemotherapy-resistant non-small cell lung cancer

✍ Sae-Won Han; Pil Gyu Hwang; Doo Hyun Chung; Dong-Wan Kim; Seock-Ah Im; Young Tae 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 351 KB 👁 1 views

## Abstract Gefitinib has shown meaningful antitumor activity with tolerable toxicity in chemotherapy‐refractory NSCLC in previous studies. Moreover, EGFR expression failed to show a correlation with response. In an attempt to identify predictive markers of response, we have investigated the tumora

Epidermal growth factor receptor and cla

Epidermal growth factor receptor and claudin-2 participate in A549 permeability and remodeling: Implications for non-small cell lung cancer tumor colonization

✍ Yakov Peter; Alejandro Comellas; Elena Levantini; Edward P. Ingenito; Steven D. 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 282 KB

## Abstract Tumor colonization involves changes in cell permeability and remodeling. Paracellular permeability is regulated by claudins, integrated tight junction (TJ) proteins, located on the apicolateral portion of epithelial cells. Epidermal growth factor (EGF) was reported to modify cellular cl

GM3 synthase gene is a novel biomarker f

GM3 synthase gene is a novel biomarker for histological classification and drug sensitivity against epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer

✍ Mariko Noguchi; Tomoko Suzuki; Kazuya Kabayama; Hiroki Takahashi; Hirofumi Chiba 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 448 KB

Epidermal growth factor receptor (EGFR)

Epidermal growth factor receptor (EGFR) mutations in a series of non-small-cell lung cancer (NSCLC) patients and response rate to EGFR-specific tyrosine kinase inhibitors (TKIs)

✍ Elena María Martínez-Navarro; Joseba Rebollo; Ramón González-Manzano; Manuel Sur 📂 Article 📅 2011 🏛 Springer Milan 🌐 Spanish ⚖ 230 KB